{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T17:07:09Z","timestamp":1793725629127,"version":"4.6.1"},"reference-count":60,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,8]],"date-time":"2024-04-08T00:00:00Z","timestamp":1712534400000},"content-version":"vor","delay-in-days":1193,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Medicine"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.7861\/clinmed.2020-0980","type":"journal-article","created":{"date-parts":[[2021,1,21]],"date-time":"2021-01-21T05:17:02Z","timestamp":1611206222000},"page":"44-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"title":["Management of functional gastrointestinal disorders"],"prefix":"10.1016","volume":"21","author":[{"given":"Asma","family":"Fikree","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.7861\/clinmed.2020-0980_bib1","doi-asserted-by":"crossref","first-page":"79.e2","DOI":"10.1053\/j.gastro.2016.02.032","article-title":"Functional gastrointestinal disorders: history, pathophysiology, clinical features and Rome IV","volume":"150","author":"Drossman","year":"2016","journal-title":"Gastroenterology"},{"key":"10.7861\/clinmed.2020-0980_bib2","article-title":"Worldwide prevalence and burden of functional gastrointestinal disorders, results of Rome Foundation global study","author":"Sperber","year":"2020","journal-title":"Gastroenterology"},{"key":"10.7861\/clinmed.2020-0980_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1176\/appi.psy.48.2.93","article-title":"Functional gastrointestinal disorders: an update for the psychiatrist","volume":"48","author":"Jones","year":"2007","journal-title":"Psychosomatics"},{"key":"10.7861\/clinmed.2020-0980_bib4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1136\/flgastro-2013-100426","article-title":"Prevalence of functional gastrointestinal disorders among consecutive new patient referrals to a gastroenterology clinic","volume":"5","author":"Shivaji","year":"2014","journal-title":"Frontline Gastroenterol"},{"key":"10.7861\/clinmed.2020-0980_bib5","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1038\/ajg.2017.421","article-title":"The prevalence and impact of overlapping rome iv-diagnosed functional gastrointestinal disorders on somatization, quality of life, and healthcare utilization: a cross-sectional general population study in three countries","volume":"113","author":"Aziz","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.7861\/clinmed.2020-0980_bib6","doi-asserted-by":"crossref","first-page":"e015594","DOI":"10.1136\/bmjopen-2016-015594","article-title":"The costs of functional gastrointestinal disorders and related signs and symptoms in infants: a systematic literature review and cost calculation for England","volume":"7","author":"Mahon","year":"2017","journal-title":"BMJ Open"},{"key":"10.7861\/clinmed.2020-0980_bib7","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1038\/s41598-020-60318-6","article-title":"Irritable bowel, chronic widespread pain, chronic fatigue and related syndromes are prevalent and highly overlapping in the general population: DanFunD","volume":"10","author":"Petersen","year":"2020","journal-title":"Sci Rep"},{"key":"10.7861\/clinmed.2020-0980_bib8","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1038\/ajg.2009.232","article-title":"Developing valid and reliable health utilities in irritable bowel syndrome: results from the IBS PROOF Cohort","volume":"104","author":"Spiegel","year":"2009","journal-title":"Am J Gastroenterol"},{"key":"10.7861\/clinmed.2020-0980_bib9","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/S0140-6736(20)32115-2","article-title":"Functional gastrointestinal disorders: advances in understanding and management","volume":"396","author":"Black","year":"2020","journal-title":"Lancet"},{"key":"10.7861\/clinmed.2020-0980_bib10","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.1016\/S0140-6736(20)30469-4","article-title":"Functional dyspepsia","volume":"396","author":"Ford","year":"2020","journal-title":"Lancet"},{"key":"10.7861\/clinmed.2020-0980_bib11","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1177\/1756283X10377126","article-title":"Managing bile acid diarrhoea","volume":"3","author":"Walters","year":"2010","journal-title":"Therap Adv Gastroenterol"},{"key":"10.7861\/clinmed.2020-0980_bib12","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S2468-1253(20)30215-6","article-title":"Standard gastroenterologist versus multidisciplinary treatment for functional gastrointestinal disorders (MANTRA): an open-label, single-centre, randomised controlled trial","volume":"5","author":"Basnayake","year":"2020","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.7861\/clinmed.2020-0980_bib13","doi-asserted-by":"crossref","first-page":"550","DOI":"10.3748\/wjg.v19.i4.550","article-title":"Colon transit time according to physical activity and characteristics in South Korean adults","volume":"19","author":"Cho","year":"2013","journal-title":"World J Gastroenterol"},{"key":"10.7861\/clinmed.2020-0980_bib14","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/ajg.2010.480","article-title":"Physical activity improves symptoms in irritable bowel syndrome: a randomized controlled trial","volume":"106","author":"Johannesson","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.7861\/clinmed.2020-0980_bib15","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1111\/j.1365-2982.2008.01181.x","article-title":"Sleep disturbances are linked to both upper and lower gastrointestinal symptoms in the general population","volume":"21","author":"Cremonini","year":"2009","journal-title":"Neurogastroenterol Motil"},{"key":"10.7861\/clinmed.2020-0980_bib16","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1136\/gut.2004.062034","article-title":"Melatonin improves abdominal pain in irritable bowel syndrome patients who have sleep disturbances: a randomised, double blind, placebo controlled study","volume":"54","author":"Song","year":"2005","journal-title":"Gut"},{"key":"10.7861\/clinmed.2020-0980_bib17","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.bpg.2017.09.006","article-title":"The role of smoking and alcohol behaviour in management of functional gastrointestinal disorders","volume":"31","author":"Ohlsson","year":"2017","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.7861\/clinmed.2020-0980_bib18","doi-asserted-by":"crossref","first-page":"E339","DOI":"10.9778\/cmajo.20180023","article-title":"The adverse health effects and harms related to marijuana use: an overview review","volume":"6","author":"Memedovich","year":"2018","journal-title":"CMAJ Open"},{"key":"10.7861\/clinmed.2020-0980_bib19","doi-asserted-by":"crossref","first-page":"974","DOI":"10.2174\/1570159X17666190603171901","article-title":"Cannabidiol adverse effects and toxicity","volume":"17","author":"Huestis","year":"2019","journal-title":"Curr Neuropharmacol"},{"key":"10.7861\/clinmed.2020-0980_bib20","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.3390\/nu11061279","article-title":"Irregular dietary habits with a high intake of cereals and sweets are associated with more severe gastrointestinal symptoms in IBS patients","volume":"11","author":"Nilholm","year":"2019","journal-title":"Nutrients"},{"key":"10.7861\/clinmed.2020-0980_bib21","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.jand.2019.01.017","article-title":"Nutrient intake, diet quality, and diet diversity in irritable bowel syndrome and the impact of the low FODMAP diet","volume":"120","author":"Staudacher","year":"2020","journal-title":"J Acad Nutr Diet"},{"key":"10.7861\/clinmed.2020-0980_bib22","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00394-015-0922-1","article-title":"Does a diet low in FODMAPs reduce symptoms associated with functional gastrointestinal disorders? A comprehensive systematic review and meta\u2013analysis","volume":"55","author":"Marsh","year":"2016","journal-title":"Eur J Nutr"},{"key":"10.7861\/clinmed.2020-0980_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.gastrohep.2015.07.009","article-title":"The low-FODMAP diet for irritable bowel syndrome: Lights and shadows","volume":"39","author":"Molina-Infante","year":"2016","journal-title":"Gastroenterol Hepatol"},{"key":"10.7861\/clinmed.2020-0980_bib24","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1053\/j.gastro.2015.07.054","article-title":"Diet low in FODMAPs reduces symptoms of irritable bowel syndrome as well as traditional dietary advice: a randomized controlled trial","volume":"149","author":"Bohn","year":"2015","journal-title":"Gastroenterology"},{"key":"10.7861\/clinmed.2020-0980_bib25","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1038\/ajg.2016.434","article-title":"A randomized controlled trial comparing the low FODMAP diet vs modified NICE guidelines in US adults with IBS\u2013D","volume":"111","author":"Eswaran","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.7861\/clinmed.2020-0980_bib26","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1053\/j.gastro.2013.04.051","article-title":"No effects of gluten in patients with self-reported non-celiac gluten sensitivity after dietary reduction of fermentable, poorly absorbed, short-chain carbohydrates","author":"Biesiekierski","year":"2013","journal-title":"Gastroenterology"},{"key":"10.7861\/clinmed.2020-0980_bib27","doi-asserted-by":"crossref","first-page":"a2313","DOI":"10.1136\/bmj.a2313","article-title":"Effect of fibre, antispasmodics, and peppermint oil in the treatment of irritable bowel syndrome: systematic review and meta\u2013analysis","volume":"337","author":"Ford","year":"2008","journal-title":"BMJ"},{"key":"10.7861\/clinmed.2020-0980_bib28","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1111\/apt.15001","article-title":"Systematic review with meta\u2013analysis: the efficacy of prebiotics, probiotics, synbiotics and antibiotics in irritable bowel syndrome","volume":"48","author":"Ford","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.7861\/clinmed.2020-0980_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.ijsu.2020.04.063","article-title":"The efficacy and safety of probiotics for patients with constipation-predominant irritable bowel syndrome: A systematic review and meta-analysis based on seventeen randomized controlled trials","volume":"79","author":"Wen","year":"2020","journal-title":"Int J Surg"},{"key":"10.7861\/clinmed.2020-0980_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41395-018-0084-x","article-title":"American College of Gastroenterology monograph on management of irritable bowel syndrome","volume":"113","author":"Ford","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.7861\/clinmed.2020-0980_bib31","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1038\/ajg.2014.148","article-title":"Effect of antidepressants and psychological therapies, including hypnotherapy, in irritable bowel syndrome: systematic review and meta\u2013analysis","volume":"109","author":"Ford","year":"2014","journal-title":"Am J Gastroenterol"},{"key":"10.7861\/clinmed.2020-0980_bib32","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12916-019-1327-4","article-title":"The classification of feeding and eating disorders in the ICD\u201311: results of a field study comparing proposed ICD\u201311 guidelines with existing ICD\u201310 guidelines","volume":"17","author":"Claudino","year":"2019","journal-title":"BMC Med"},{"key":"10.7861\/clinmed.2020-0980_bib33","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ajg.2011.340","article-title":"Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials","volume":"107","author":"Lindfors","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.7861\/clinmed.2020-0980_bib34","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/j.brat.2010.03.003","article-title":"Internet-delivered exposure and mindfulness based therapy for irritable bowel syndrome-a randomized controlled trial","volume":"48","author":"Ljotsson","year":"2010","journal-title":"Behav Res Ther"},{"key":"10.7861\/clinmed.2020-0980_bib35","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.beth.2018.05.002","article-title":"Internet-delivered exposure-based cognitive-behavioral therapy for adolescents with functional abdominal pain or functional dyspepsia: a feasibility study","volume":"50","author":"Bonnert","year":"2019","journal-title":"Behav Ther"},{"key":"10.7861\/clinmed.2020-0980_bib36","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1111\/j.1365-2036.2007.03437.x","article-title":"Clinical trial: short- and long-term benefit of relaxation training for irritable bowel syndrome","volume":"26","author":"van der Veek","year":"2007","journal-title":"Aliment Pharmacol Ther"},{"key":"10.7861\/clinmed.2020-0980_bib37","doi-asserted-by":"crossref","first-page":"414","DOI":"10.3109\/00365521.2012.658858","article-title":"Long-term effects of hypnotherapy in patients with refractory irritable bowel syndrome","volume":"47","author":"Lindfors","year":"2012","journal-title":"Scand J Gastroenterol"},{"key":"10.7861\/clinmed.2020-0980_bib38","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/ajg.2011.340","article-title":"Effects of gut-directed hypnotherapy on IBS in different clinical settings-results from two randomized, controlled trials","volume":"107","author":"Lindfors","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.7861\/clinmed.2020-0980_bib39","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.brat.2010.10.006","article-title":"Long-term follow-up of internet-delivered exposure and mindfulness based treatment for irritable bowel syndrome","volume":"49","author":"Ljotsson","year":"2011","journal-title":"Behav Res Ther"},{"key":"10.7861\/clinmed.2020-0980_bib40","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0016-5085(03)00669-3","article-title":"Cognitive-behavioral therapy versus education and desipramine versus placebo for moderate to severe functional bowel disorders","volume":"125","author":"Drossman","year":"2003","journal-title":"Gastroenterology"},{"key":"10.7861\/clinmed.2020-0980_bib41","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S2468-1253(16)30116-9","article-title":"Management of the multiple symptoms of irritable bowel syndrome","volume":"2","author":"Simren","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.7861\/clinmed.2020-0980_bib42","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1038\/nrgastro.2014.53","article-title":"Diagnosis and treatment of narcotic bowel syndrome","volume":"11","author":"Kurlander","year":"2014","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.7861\/clinmed.2020-0980_bib43","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1097\/JCP.0000000000000599","article-title":"An open-label pilot study of duloxetine in patients with irritable bowel syndrome and comorbid major depressive disorder","volume":"36","author":"Lewis\u2013Fernandez","year":"2016","journal-title":"J Clin Psychopharmacol"},{"key":"10.7861\/clinmed.2020-0980_bib44","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3109\/13651501.2013.838632","article-title":"An open-label trial of duloxetine in patients with irritable bowel syndrome and comorbid generalized anxiety disorder","volume":"18","author":"Kaplan","year":"2014","journal-title":"Int J Psychiatry Clin Pract"},{"key":"10.7861\/clinmed.2020-0980_bib45","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/apt.15077","article-title":"Randomised clinical trial: pregabalin vs placebo for irritable bowel syndrome","volume":"49","author":"Saito","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.7861\/clinmed.2020-0980_bib46","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1111\/j.1365-2036.2005.02685.x","article-title":"Gabapentin reduces rectal mechanosensitivity and increases rectal compliance in patients with diarrhoea-predominant irritable bowel syndrome","volume":"22","author":"Lee","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.7861\/clinmed.2020-0980_bib47","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1185\/030079907X182176","article-title":"Randomized, double\u2013blind, placebo-controlled clinical trial of loperamide plus simethicone versus loperamide alone and simethicone alone in the treatment of acute diarrhea with gas-related abdominal discomfort","volume":"23","author":"Hanauer","year":"2007","journal-title":"Curr Med Res Opin"},{"key":"10.7861\/clinmed.2020-0980_bib48","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1136\/gutjnl-2013-305989","article-title":"A randomised trial of ondansetron for the treatment of irritable bowel syndrome with diarrhoea","volume":"63","author":"Garsed","year":"2014","journal-title":"Gut"},{"key":"10.7861\/clinmed.2020-0980_bib49","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1136\/gutjnl-2018-318160","article-title":"Efficacy of pharmacological therapies in patients with IBS with diarrhoea or mixed stool pattern: systematic review and network meta\u2013analysis","volume":"69","author":"Black","year":"2020","journal-title":"Gut"},{"key":"10.7861\/clinmed.2020-0980_bib50","doi-asserted-by":"crossref","first-page":"e2534","DOI":"10.1097\/MD.0000000000002534","article-title":"Rifaximin for irritable bowel syndrome: a meta-analysis of randomized placebo-controlled trials","volume":"95","author":"Li","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.7861\/clinmed.2020-0980_bib51","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.14309\/ajg.0000000000000327","article-title":"Efficacy and safety of eluxadoline in patients with irritable bowel syndrome with diarrhea who report inadequate symptom control with loperamide: RELIEF phase 4 study","volume":"114","author":"Brenner","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.7861\/clinmed.2020-0980_bib52","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/2050640612474651","article-title":"Efficacy and safety of oral prucalopride in women with chronic constipation in whom laxatives have failed: an integrated analysis","volume":"1","author":"Tack","year":"2013","journal-title":"United European Gastroenterol J"},{"key":"10.7861\/clinmed.2020-0980_bib53","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1136\/gut.2008.162404","article-title":"Prucalopride (Resolor) in the treatment of severe chronic constipation in patients dissatisfied with laxatives","volume":"58","author":"Tack","year":"2009","journal-title":"Gut"},{"key":"10.7861\/clinmed.2020-0980_bib54","doi-asserted-by":"crossref","first-page":"e0134349","DOI":"10.1371\/journal.pone.0134349","article-title":"Linaclotide in chronic idiopathic constipation patients with moderate to severe abdominal bloating: a randomized, controlled trial","volume":"10","author":"Lacy","year":"2015","journal-title":"PLoS One"},{"key":"10.7861\/clinmed.2020-0980_bib55","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1038\/ajg.2017.230","article-title":"Low-dose linaclotide (72 mug) for chronic idiopathic constipation: a 12-week, randomized, double-blind, placebo-controlled trial","volume":"113","author":"Schoenfeld","year":"2018","journal-title":"Am J Gastroenterol"},{"key":"10.7861\/clinmed.2020-0980_bib56","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1111\/apt.13807","article-title":"Effects of baseline abdominal pain and bloating on response to lubiprostone in patients with irritable bowel syndrome with constipation","volume":"44","author":"Chang","year":"2016","journal-title":"Aliment Pharmacol Ther"},{"key":"10.7861\/clinmed.2020-0980_bib57","first-page":"CD009431","article-title":"Prokinetics for functional dyspepsia","volume":"10","author":"Pittayanon","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.7861\/clinmed.2020-0980_bib58","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1136\/gutjnl-2015-310721","article-title":"Efficacy of psychotropic drugs in functional dyspepsia: systematic review and meta\u2013analysis","volume":"66","author":"Ford","year":"2017","journal-title":"Gut"},{"key":"10.7861\/clinmed.2020-0980_bib59","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S2468-1253(18)30303-0","article-title":"Low-dose imipramine for refractory functional dyspepsia: a randomised, double-blind, placebo-controlled trial","volume":"3","author":"Cheong","year":"2018","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.7861\/clinmed.2020-0980_bib60","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.cgh.2015.09.043","article-title":"Efficacy of mirtazapine in patients with functional dyspepsia and weight loss","volume":"14","author":"Tack","year":"2016","journal-title":"Clin Gastroenterol Hepatol"}],"container-title":["Clinical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824033700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1470211824033700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.7861\/clinmed.2020-0980","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,23]],"date-time":"2025-04-23T02:57:02Z","timestamp":1745377022000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1470211824033700"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S1470211824033700"],"URL":"https:\/\/doi.org\/10.7861\/clinmed.2020-0980","relation":{},"ISSN":["1470-2118"],"issn-type":[{"value":"1470-2118","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of functional gastrointestinal disorders","name":"articletitle","label":"Article Title"},{"value":"Clinical Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.7861\/clinmed.2020-0980","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 Royal College of Physicians 2021. All rights reserved.","name":"copyright","label":"Copyright"}]}}